Literature DB >> 19013033

Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line.

Rui Wang1, Bin Li, Xi Wang, Fang Lin, Ping Gao, Shi-Yin Cheng, Hui-Zhong Zhang.   

Abstract

OBJECTIVES: X-linked inhibitor of apoptosis protein (XIAP) is a novel member of the inhibitors of apoptosis (IAPs) family. The overexpression of XIAP is asscociated with radioresistance of human malignancies. The purpose of the present study was to investigate the effect of shRNA-targeted XIAP on the proliferation, apoptosis and radiosensitivity of human laryngeal carcinoma cells (Hep-2).
METHODS: A siRNA expression vector (pSilencer4.1-XIAPshRNA) was constructed and stably transfected into human laryngeal carcinoma cells (Hep-2). The downregulation of XIAP expression was evaluated by RT-PCR and Western blot analyses. Then, we investigated the effect of XIAP-shRNA on the proliferation, cell cycle changes and apoptosis in vitro of Hep-2 cells. Finally, the radiosensitivity of Hep-2 cells was investigated by clonogenic cell survival assay.
RESULTS: We established stably transfected cell line (Hep-2/XIAPshRNA) in which the expression of XIAP gene was downregulated. The cell viability of Hep-2/XIAP-RNA cells was obviously decreased compared with that of untransfected Hep-2 cells. Morever, XIAP-shRNA induced cell arrest in the G(0)/G(1) phase of cell cycle by flow cytometry analysis. Results of TUNEL assay indicated that Hep-2 cells stably transfected pSilencer4.1-XIAP-shRNA showed obvious apoptosis characters. Furthermore, the downregulation of XIAP expression could lead to significant radiosensitivity enhancement in laryngeal carcinoma cells.
CONCLUSIONS: RNAi-mediated downregulation of XIAP expression can inhibit proliferation, induce apoptosis and diminish the radioresistance of laryngeal carcinoma cells, so combined therapy with XIAP inhibition and radiation may be a potential strategy for the treatment of laryngeal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013033     DOI: 10.1016/j.anl.2008.08.006

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  12 in total

1.  Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.

Authors:  Chun Jiang; Xiao-Ping Yi; Hong Shen; Yi-Xiong Li
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

2.  X-linked inhibitor of apoptosis protein (XIAP) regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/c-Jun axis.

Authors:  Zipeng Cao; Ruowen Zhang; Jingxia Li; Haishan Huang; Dongyun Zhang; Jingjie Zhang; Jimin Gao; Jingyuan Chen; Chuanshu Huang
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

3.  A bioinformatics filtering strategy for identifying radiation response biomarker candidates.

Authors:  Jung Hun Oh; Harry P Wong; Xiaowei Wang; Joseph O Deasy
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

Review 4.  Targeting IAP proteins in combination with radiotherapy.

Authors:  Simone Fulda
Journal:  Radiat Oncol       Date:  2015-04-26       Impact factor: 3.481

5.  MicroRNA-24 inhibits growth, induces apoptosis, and reverses radioresistance in laryngeal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein.

Authors:  Li Xu; Zhifeng Chen; Fei Xue; Wei Chen; Ruina Ma; Shiyin Cheng; Pengcheng Cui
Journal:  Cancer Cell Int       Date:  2015-06-17       Impact factor: 5.722

6.  Potential biological process of X-linked inhibitor of apoptosis protein in renal cell carcinoma based upon differential protein expression analysis.

Authors:  Chao Chen; Si Cong Zhao; Wen Zheng Yang; Zong Ping Chen; Yong Yan
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

7.  Tan IIA inhibits H1299 cell viability through the MDM4‑IAP3 signaling pathway.

Authors:  Yukun Zu; Jianning Wang; Wei Ping; Wei Sun
Journal:  Mol Med Rep       Date:  2017-11-24       Impact factor: 2.952

8.  Comparative proteomic study of dog and human saliva.

Authors:  Phutsa Sanguansermsri; Howard F Jenkinson; Jitkamol Thanasak; Kongthawat Chairatvit; Sittiruk Roytrakul; Suthathip Kittisenachai; Duangchewan Puengsurin; Rudee Surarit
Journal:  PLoS One       Date:  2018-12-04       Impact factor: 3.240

9.  Prognostic significance of XIAP and NF-κB expression in esophageal carcinoma with postoperative radiotherapy.

Authors:  Suna Zhou; Wenguang Ye; Qiuju Shao; Yuhong Qi; Mingxin Zhang; Jun Liang
Journal:  World J Surg Oncol       Date:  2013-11-05       Impact factor: 2.754

10.  XIAP underlies apoptosis resistance of renal cell carcinoma cells.

Authors:  Wen Zheng Yang; Haijiang Zhou; Yong Yan
Journal:  Mol Med Rep       Date:  2017-10-27       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.